Pi Pharma Intelligence’s Contributions Extend Beyond the Pharmaceutical Industry to Include Academia
AchievementWe are glad to see Pi Pharma Intelligence rising as a trusted provider of data, Today marks our first contribution to an article published at the Annals of Pharmacotherapy on Economic Evaluation of Three BRAF + MEK Inhibitors for the Treatment of Advanced Unresectable Melanoma with BRAF Mutation, we thank all the authors for their trust and special thanks to our advisor Dr.Nimer Alkhatib
Pi Pharma Intelligence is selected as a StarVenture by European Bank for Reconstruction and Development
May, 2023
Pi Pharma Intelligence is selected as a StarVenture by European Bank for Reconstruction and Development
Pi Pharma Intelligence Have Participated in The Investor Readiness Program as Part From SURGE Program.
Jun, 2023
Pi Pharma Intelligence Have Participated in The Investor Readiness Program as Part From SURGE Program.
Pi Pharma Teams Up with Taktika for Team Trainings
Sep, 2022
Pi Pharma Teams Up with Taktika for Team Trainings